University of Cambridge > > euroscicon > The 2014 Pathology Congress

The 2014 Pathology Congress

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Speaker to be confirmed.

This meeting draws together international experts to discuss current techniques and research involved in cellular and molecular pathology. This year focuses on three specific areas:-

  • Progress in Molecular and Cellular Pathology
  • Developments in immunohistochemistry for diagnostic cellular pathology
  • Biomarkers
  • Histopathology and Cytopathology: Advances in research and techniques

With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding pathology. This meeting gathers together workings from clinical, academic and pharmaceutical organisations.

This event has CPD accreditation

This event has an open oral and poster session. Abstracts can be submitted on any subject related to pathology

The Deadline for abstract submissions for oral presentation is August 10th 2014 Abstracts for poster presentation only can be submitted up to two weeks before the event . You can download the instructions for authors at

Who Should Attend All who need to be at the leading edge of developments in this area will find this attendance at this conference rewarding. Attendance is recommended to both professionals and students within the diagnostic and research communities that engage with pathology.

Program Outline

Day 1: Progress in Molecular and Cellular Pathology This session will discuss current topics presented by experts in their fields of research and practice. Placed in the context of molecular cellular pathology presentations will explore disease mechanisms, clinical advances and latest technology breakthroughs.

Day 2: Developments in immunohistochemistry for diagnostic cellular pathology Developments in Immunohistochemistry (IHC) techniques and technology to aid the improvements needed to boost and strengthen the use of IHC in future diagnostic pathology practice will be discussed

Day 3:

Morning: Biomarkers Biomarkers identifying biological and physiological entities associated with disease are taking an increasingly important place at the tables of drug discovery and personalised medicine. Their discovery in biosamples requires the combined use of genomics, proteomics and bioinformatics platforms. Whilst for their application, robust techniques combining exquisite sensitivity and specificity must be developed. This conference is focused on technologies that are driving advances in this area and their application at gene and expression level in solid and fluid biosamples. As such this session is targeted to provide leading edge information to researchers within the academic, biotechnology and pharmaceutical sectors.

Afternoon: Histopathology and Cytopathology: Advances in research and techniques Drawing together international experts to discuss the need for technical-based updates in the areas of immunohistochemistry and cytopathology, clinical and research based histopathology, cytopathology and in situ hybridisation.

This talk is part of the euroscicon series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity